| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $152K | — | +499.6% |
| Cost of Revenue | $242K | — | — |
| R&D Expense | $660K | — | -71.3% |
| SG&A Expense | $2.2M | — | -2.6% |
| Operating Income | -$3.0M | — | +34.5% |
| Net Income | -$3.0M | — | +31.5% |
| EPS (Basic) | -$0.21 | — | +58.0% |
| EPS (Diluted) | -$0.21 | — | +58.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.5M | -25.1% | +79.3% |
| Current Assets | $21.7M | -20.0% | +83.2% |
| Total Assets | $27.8M | -14.3% | +49.5% |
| Current Liabilities | $21.1M | -10.8% | -0.3% |
| Total Liabilities | $27.1M | -8.6% | -3.9% |
| Stockholders' Equity | $734K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.5M | — | -0.9% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | -$715K | — | -390.2% |
| Free Cash Flow | -$5.5M | — | +1.9% |
| +107.7% |